Based out of Bengaluru, Coeo Labs is building two products to create a palpable, lasting impact in the healthcare space and decrease infant mortality. Their first product VAPCare focuses on reducing the chances of ventilator associated pneumonia in the ICU by Artificial Intelligence and sensor-based secretion management from the three oral, oropharyngeal, and subglottic regions. Their second product is a neonatal continuous positive airway pressure (CPAP) device to reduce respiratory distress in babies and improves chances of survival by 24 to 65 percent.